Systematic review of machine learning in the pharmaceutical industry

More data nearly always generates better outcomes when it comes to machine learning effectiveness—and the healthcare sector is sitting on a data bonanza. Many pharma businesses think that big data and machine learning in the pharma industry might provide greater value and profit while undertaking a systematic review. It is founded on optimal innovation, enhanced research/clinical trials, better decision-making, and the development of new tools for physicians, patients, insurers, and regulators.